The report “Pyrogen Testing Market by Product (Instruments, Services, Kits & Reagents), by Test (In Vitro, LAL, Rabbit Test), by Application (Pharmaceutical & Biotechnology Companies, Medical Devices, Other Applications) - Global Forecast to 2019”, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, Trends, current market trends, and strategies impacting the global pyrogen testing market along with the estimates and forecasts of the revenue and market share analysis.

Browse 76 market data tables and 98 figures spread through 175 pages and in-depth TOC on “Pyrogen Testing Market

http://www.marketsandmarkets.com/Market-Reports/pyrogen-testing-market-255266155.html
Early buyers will receive 10% customization on reports.

The increasing number of new biologics products launched will be one of the most important growth drivers for this market in the forecast period (2014-2019). The number of new pharmaceutical products launched annually witnessed a strong upward trend between 2003 and 2013. The number of new products launched in 2013 was 56 as compared to 29 in 2003. The biologics pipeline has increased by 155%, from 355 treatments in 2001 to 907 in 2012. A strong pharmaceutical product pipeline will aid the growth of the pharmaceutical and biotechnology industries, which is an important end user of pyrogen testing products. According to the Ernst & Young’s ‘Global Biotechnology Report 2013’, companies in biotechnology centers in the U.S., Europe, Canada, and Australia achieved revenues of about $90 billion in 2012. This was an 8% increase over the revenues in 2011. According to OECD estimates, in 2011, the total number of biotechnology companies in the U.S. was 7,970, followed by Spain (3,025 biotechnology companies), and France (1,481 biotechnology companies). Owing to the rise in the number of biotechnology companies, biopharmaceutical production has increased globally.

Download PDF brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=255266155

Major players in the pyrogen testing market include Associates of Cape Cod, Inc. (U.S.), Charles River Laboratories International, Inc. (U.S.), Ellab A/S (Denmark), GenScript (U.S.), Hyglos GmbH (Germany), Lonza Group (Switzerland), Merck & Co., Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Wako Chemicals USA, Inc. (U.S.).

Request sample of this report@ http://www.marketsandmarkets.com/requestsample.asp?id=255266155

The global pyrogen testing market is segmented on the basis of applications, products, tests, and geographies. By application, the market is divided into pharmaceuticals and biologicals, medical devices, and other applications such as water purification, food and beverages, cosmetics, and plastics and glass products. Of these, the pharmaceuticals and biologicals application segment accounted for the largest share of the global pyrogen testing market in 2014. The product segments included in this report are instruments, kits and reagents, and services. By test, the market is segmented into in vitro pyrogen test, LAL test, and rabbit test. The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). The Asian segment is further divided into China, India, Japan, and the Rest of Asia. Europe is divided into France, Germany, Italy, Spain, the U.K., and the Rest of Europe. North America includes Canada and the U.S. The RoW encompasses Africa; Pacific and Oceania; and South America, Central America, and the Caribbean.